跳至主要内容
临床试验/JPRN-UMIN000007703
JPRN-UMIN000007703已完成未知

Renoprotective effects of HMG/CoA reductase inhibitor on patients with hyperlipidemia associated with renal insufficiency-Effect of atorvastatin by switching from other statins- - Renoprotective effects of atorvastatin

Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Chiba University Hospital0 个研究点目标入组 30 人开始时间: 2012年4月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The exclusion criteria were an age >70 years, current history of myocardial infarction and/or cerebral stroke, uncontrollable hypertension and hyperglycemia, renal failure, abnormal liver or muscle enzymes (ALT>100, ALT>100), patients who applied for other clinical trial within 3 months, expectant mother, lactating woman, patients who had taken ACE-I and/or ARB within 3 months, inappropriate patients judged by the physician in charge

研究者

发起方
Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Chiba University Hospital

相似试验